Home Variation of barrier permeability for albumin and immunoglobulin G influx into cerebrospinal fluid
Article
Licensed
Unlicensed Requires Authentication

Variation of barrier permeability for albumin and immunoglobulin G influx into cerebrospinal fluid

  • Sepp Seyfert , Sabine Quill and Andreas Faulstich
Published/Copyright: June 24, 2009

Abstract

Background: The aim of the present study was to analyze variations in permeability of albumin and immunoglobulin G (IgG) influx into cerebrospinal fluid (CSF) in a clinical setting.

Methods: In a retrospective intra-individual comparison of CSF samples, we used the IgGIndex and its constituents to indicate alterations in IgG/albumin permeability.

Results: We found altered IgGIndices in 25/64 patients (range –25% to +44%), with differently altered QAlb and QIgG values (–69% to +549%), unaltered IgG-Indices in a further 25/64 patients with equally altered QAlb and QIgG values (–46% to +107%), and no parameter alteration in 14/64 patients. Parameter alterations in 25/64 patients indicated that permeability of albumin was changed to different extents than for IgG. It changed in the same direction in 20/25 patients, and the opposite in five patients. In further 25/64 patients, equal QAlb and QIgG alterations indicated equally altered permeabilities and/or altered efflux of the proteins. In 14/64 patients, no alteration in permeability or efflux was seen.

Conclusions: Results revealed surprisingly variable intra-individual changes in permeabilities for albumin and IgG in pathologic as well as normal CSF. Differing changes in permeability indicate that the diffusion paths of the two proteins may react to disturbances independently of each other. The details of the influx permeability for albumin and IgG into CSF illustrate the prospect of a more comprehensive insight into the protein exchange between blood and CSF.

Clin Chem Lab Med 2009;47:955–8.


Corresponding author: Sepp Seyfert, MD, Department of Neurology, CBF Charite, 12200 Berlin, Germany Phone: +49-30-8445-2276, Fax: +49-30-8445-4264

Received: 2009-3-18
Accepted: 2009-4-30
Published Online: 2009-06-24
Published in Print: 2009-08-01

©2009 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorial
  2. Hemolysis index: quality indicator or criterion for sample rejection?
  3. Review
  4. Neutrophil CD64: a diagnostic marker for infection and sepsis
  5. Genetics and Molecular Diagnostics
  6. Chromosome 9p21 polymorphism is associated with myocardial infarction but not with clinical outcome in Han Chinese
  7. Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia
  8. Clinical, biochemical, and genetic analysis of a Korean neonate with hereditary tyrosinemia type 1
  9. General Clinical Chemistry and Laboratory Medicine
  10. Multicenter evaluation of the hemolysis index in automated clinical chemistry systems
  11. Haemolysis index – an estimate of preanalytical quality in primary health care
  12. Evaluation of the Innovance D-DIMER analytical performance
  13. Heterophile antibodies may falsely increase or decrease thyroglobulin measurement in patients with differentiated thyroid carcinoma
  14. Variation of barrier permeability for albumin and immunoglobulin G influx into cerebrospinal fluid
  15. Anti-citrullinated protein antibody and rheumatoid factor in patients with end-stage renal disease
  16. Reference Values and Biological Variations
  17. Quality of interpretative commenting on common clinical chemistry results in the Asia-Pacific region and Africa
  18. Analysis and interpretation of drug testing results from patients on chronic pain therapy: a clinical laboratory perspective
  19. Cancer Diagnostics
  20. HER1-4 protein concentrations in normal breast tissue from breast cancer patients are expressed by the same profile as in the malignant tissue
  21. Comparison of fifteen immunoassays for the measurement of serum MUC-1/CA 15-3 in breast cancer patients
  22. Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers
  23. Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma
  24. Relationship of serum antioxidant micronutrients and sociodemographic factors to cervical neoplasia: a case-control study
  25. Letters to the Editor
  26. Clinical efficacy of two cardiac troponin I assays
  27. Impeded centrifugation in plasmocytoma serum
Downloaded on 15.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.211/html
Scroll to top button